{"entities":{"Q6976485":{"pageid":21361956,"ns":120,"title":"Item:Q6976485","lastrevid":84035657,"modified":"2026-05-08T11:45:37Z","type":"item","id":"Q6976485","labels":{"en":{"language":"en","value":"A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk"}},"descriptions":{"en":{"language":"en","value":"scientific article; zbMATH DE number 8048132"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$A606958F-4443-402E-B8C4-B25DC0945545","rank":"normal"}],"P159":[{"mainsnak":{"snaktype":"value","property":"P159","hash":"e43e58ed72091fe04637ce6aa8c738446a52e0d0","datavalue":{"value":{"text":"A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q6976485$BC248D99-6657-48FB-A80C-232717282899","rank":"normal"}],"P225":[{"mainsnak":{"snaktype":"value","property":"P225","hash":"7a12ab7c755f668131c6ac84c8bbcb1fa3ceb569","datavalue":{"value":"1562.62178","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6976485$61FBE1E6-4AFD-4116-B398-0D752CC2CBEB","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"74ff9d064643b228006d4f0ec4c1efbfcbd1712a","datavalue":{"value":"10.1002/SIM.5731","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6976485$A67CECDE-8A03-4582-86E2-023150431518","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"a3034d7b31faf3e8a1ad7373ea4d9c2ae42ffc18","datavalue":{"value":{"entity-type":"item","numeric-id":6976482,"id":"Q6976482"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$062DC35F-0265-4B59-94EC-B2F73002E531","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"7c0feb122d71ed93366b1d2853163840c1a000bf","datavalue":{"value":{"entity-type":"item","numeric-id":3367571,"id":"Q3367571"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$24DE28A9-C088-41A4-B987-24E22D044B11","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"932c6b68db297587f8fc11a3b67090a43805f66c","datavalue":{"value":{"entity-type":"item","numeric-id":6976483,"id":"Q6976483"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$F23E3C42-2DE5-4388-B8F8-D5E7A46CF252","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"bc5c572b8ba389a394fbd3dc9c1aacc7b19f5fa4","datavalue":{"value":{"entity-type":"item","numeric-id":6976484,"id":"Q6976484"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$B1CFCC10-91E8-4C4E-9F13-E05A1E371BFC","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"f176889fea30d36256fbae63fbc48f1ea28cd207","datavalue":{"value":{"entity-type":"item","numeric-id":57552,"id":"Q57552"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$CE17AF00-10E4-429E-9654-AD1B08C5C427","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"b1d287cb8d96589c2cc587d8d419d31e18e77b38","datavalue":{"value":{"time":"+2025-06-02T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q6976485$71AEA3B4-008D-4D5E-B8E0-7A208536CB58","rank":"normal"}],"P226":[{"mainsnak":{"snaktype":"value","property":"P226","hash":"708a6f1a75f978962215fcdf6748c16c77f4fd6e","datavalue":{"value":"62P10","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6976485$E882554C-A291-4B42-A054-0F934991FB4C","rank":"normal"}],"P1451":[{"mainsnak":{"snaktype":"value","property":"P1451","hash":"5eb77d925b6ec1f77fc4ad8e959e3e32d31234ab","datavalue":{"value":"8048132","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6976485$09D4B907-A743-415B-A181-1B4B8879D846","rank":"normal"}],"P1450":[{"mainsnak":{"snaktype":"value","property":"P1450","hash":"c2fb5fbf419b0810c93ea37d2f0f971535e54c03","datavalue":{"value":"phase 3 portfolio optimization","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$77D4F832-24D1-4A10-9CE3-E31173D7868B","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"7006d7e444605bb58ab217fb639621d162ce3126","datavalue":{"value":"budget constraints","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$2A3A2BD5-2B4F-40A2-AFB3-29B9DD1B5AC8","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"6de5291298e0dcc58ce86e8a022fe51a9c95e365","datavalue":{"value":"decision analysis","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$72CE02DF-847F-450E-B578-E29A6E948619","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"93ff78e2fea6964a9c20dc2bd66d3292b750bf29","datavalue":{"value":"stochastic integer programming","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$63F5ECE4-CFA4-4A99-A202-8C16A798E849","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"960b4e9f98808bed03c747e698ff716dd771c437","datavalue":{"value":"risk","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$08A5E50D-4657-4A43-B690-9749A822BB87","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"1f3bf54b7aaba262447c01b01313fe2c2c15dd10","datavalue":{"value":"portfolio re-optimization","type":"string"},"datatype":"string"},"type":"statement","id":"Q6976485$1D424468-B3C7-4AB8-B96B-1A7696788928","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$62111D83-FD91-4AD8-A77E-30BD85C37658","rank":"normal"}],"P223":[{"mainsnak":{"snaktype":"value","property":"P223","hash":"087d7485392295a5d8d92acb970b000323501021","datavalue":{"value":{"entity-type":"item","numeric-id":992625,"id":"Q992625"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$1C8D0395-858D-449F-905B-E5190A14425C","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"f754b102dd2e3fae960983fea8fab45fcf81210b","datavalue":{"value":{"entity-type":"item","numeric-id":1766323,"id":"Q1766323"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$92962EA2-7B77-497D-BAF2-1DEF762D1E88","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"c667e6cfba215329b0c035de19866bbdc9de8248","datavalue":{"value":{"entity-type":"item","numeric-id":5314563,"id":"Q5314563"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$EB1B0906-C703-4299-ACB7-27699A460F97","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"01f3fb3e1fae29aed1c6cc2c2471ebb5b2c96cc0","datavalue":{"value":{"entity-type":"item","numeric-id":3008815,"id":"Q3008815"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$608D95CB-4617-468E-82E2-584EF5AEC9F5","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"24542bf75755823c228d09ab4244f04a3422f565","datavalue":{"value":{"entity-type":"item","numeric-id":4180077,"id":"Q4180077"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6976485$DE50624F-800C-4373-8AA1-7FD305B50523","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/A_mathematical_model_for_maximizing_the_value_of_phase_3_drug_development_portfolios_incorporating_budget_constraints_and_risk"}}}}}